IPO documents reveal potential of clinic’s collaboration with Evelo Biosciences.
Powered by the Mayo Clinic’s AI, research claims it can read blood potassium with a touch.
Method uses newly-discovered molecular targets to make deadly tumors more vulnerable.
Medicool Technologies is looking to halt atrial fibrillations painlessly with a new, novel implant.
San Francisco anti-aging firm seeks $85 million for clinical trials using Mayo intelligence.
Use of ‘liquid biopsies’ to track disease progression found to be feasible.
The shuttered 1920s theater will host ‘interim uses’ with a $1 million infusion.
Thaddeus Medical is in line for $50K, while Hunhu Medical declared a loss in its report to the city.